glp-1 news november 6 2025 Lilly, chasing Novo, expects second-quarter FDA decision on obesity pill Alarming rise in weight loss

Several factors may contribute to dizziness in patients taking GLP-1 medications: Hypoglycaemia (low blood glucose) particularly when GLP-1 agonists are used alongside other glucose-lowering medications such as sulphonylureas or insulin Dehydration resulting from reduced fluid intake due to decreased appetite or from gastrointestinal side effects such as nausea, vomiting, or diarrhoea Orthostatic hypotension a drop in blood pressure upon standing, which may occur due to volume depletion or rapid weight loss Reduced caloric intake significant appetite suppression may lead to inadequate nutrition, potentially causing weakness and dizziness The frequency and severity of dizziness vary between individuals and specific GLP-1 products

GHK-Cu is observed to exhibit multifunctional properties in reparative processes but requires evaluation for purity and efficacy

Who is TAD 2500 For

Store tightly closed and use within one week after opening